Effective single-drug approach is welcomed for deep-vein thrombosis treatment.
D002986:Clinical Trials as Topic; D003226:Congresses as Topic; D005060:Europe; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D009025:Morpholines / Q000008:administration & dosage*; D000069552:Rivaroxaban; D013876:Thiophenes / Q000008:administration & dosage*; D020246:Venous Thrombosis / Q000188:drug therapy* / Q000517:prevention & control
D005343:Fibrinolytic Agents; D009025:Morpholines; D013876:Thiophenes; D000069552:Rivaroxaban